Jul 31, 2018
BioPharmX Receives IRB Approval to Initiate Phase 2 Trial of BPX-04 for the Treatment of Rosacea
Jul 19, 2018
BioPharmX Announces FDA Grant of CARC Waiver and Post-Hoc Analysis for BPX-01
May 24, 2018
BioPharmX Studies Show Hydrophilic Topical Minocycline Gels May Be the Preferred Treatment Option for Acne, Rosacea Patients
Apr 30, 2018
$20 Million Class Action Settlement has been Reached for Purchasers of Solodyn®
Apr 05, 2018
If You Purchased Solodyn® and/or Its Generic Equivalent You Could Get Money from a Class Action Lawsuit Settlement
Mar 20, 2018
U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug Compositions
Feb 20, 2018
Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets
Feb 06, 2018
Periodontal Therapeutics Market, 2025 - Key Companies are 3M, Valeant Pharmaceuticals, Inc., Kaken Pharmaceuticals Co. Ltd., Den-Mat Holdings, LLC, Dexcel Pharma and Galderma S.A.
Jan 26, 2018
BioPharmX To Present Data On New Fluorescence Lifetime Imaging Microscopy to Measure How Effectively Topically Applied Minocycline Reaches Targets in Skin
Jan 12, 2018
BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month
Dec 13, 2017
Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
Dec 06, 2017
Mino-Lok(TM) Phase 3 Clinical Trial Supplies Shipped to Sites
Dec 04, 2017
BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Treatment of Acne at ASCB 2017
Dec 04, 2017
BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Treatment of Acne at ASCB 2017
Oct 18, 2017
BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017
Oct 11, 2017
BioPharmX Collaborates with Wellman Center for Photomedicine to Develop Pioneering, Cost-Effective Technique to Visualize Drug Delivery
Sep 12, 2017
BioPharmX Announces Preliminary Data from Rosacea Feasibility Study
Aug 03, 2017
Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
Jul 27, 2017
Summer AAD Panel to Discuss BPX-01 for Acne and Rosacea
Jun 22, 2017
BioPharmX to Present Phase 2b Clinical Trial Acne Data at Alabama Dermatology Society Summer Symposium